An evaluation of the incidence of hyperparathyroidism after 131I treatment for Basedow disease (Part I)

Kakuigaku

Volumn 33, Issue 7, 1996, Pages 729-735

  Tsuchiya, Takehiko ^a  

^a ITO HOSPITAL   (Japan)

Author keywords

131I therapy; Basedow disease; Calcium; Hyperparathyroidism; Parathyroid hormone

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGING; ARTICLE; CALCIUM TRANSPORT; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERPARATHYROIDISM; INCIDENCE; IRRADIATION; MAJOR CLINICAL STUDY; MALE; RADIOISOTOPE THERAPY;

ADULT; AGE FACTORS; AGED; ANTITHYROID AGENTS; CALCIUM; FEMALE; GRAVES DISEASE; HUMANS; HYPERPARATHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PARATHYROID HORMONE; RADIATION DOSAGE; RADIOTHERAPY;

EID: 0029816855     PISSN: 00227854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Rosen IB, Strawbridge HG, Brain J: A case of hyperparathyroidism associated with radiation to the head and neck area. Cancer 36 (3): 1111-1114, 1975
2. Tisell LE, Carlson S, Lindberg S, Ragnhult I: Autonomous hyperparathyroidism (A possible late complication of neck radiotherapy). Acta Chir Scand 142: 367-373, 1976
3. Hedman I, Haussen G, Lundberg LM, Tisell LE: A clinical evaluation of radiation-induced hyperparathyroidism based on 148 surgically treated patients. World J Surg 8: 96-105, 1984
4. Tisell LE, Carlsson S, Fjälling M, Hansson G, Lindberg S, et al: Hyperparathyroidism subsequent to neck irradiation. Cancer 56: 1529-1533, 1985